Equity Overview
Price & Market Data
Price: $8.39
Daily Change: -$0.57 / 6.79%
Range: $8.20 - $8.86
Market Cap: $481,050,752
Volume: 232,108
Performance Metrics
1 Week: -4.44%
1 Month: 22.66%
3 Months: -19.25%
6 Months: -66.51%
1 Year: -60.08%
YTD: -48.97%
Company Details
Employees: 52
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, as well as in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.